Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - OTHER CURRENT LIABILITIES
Other Current Liabilities RARE - Ultragenyx Pharmaceutical Inc.
295 M
LAST VALUE
23.69%
2 YEAR CAGR
31.18%
5 YEAR CAGR
44.07%
10 YEAR CAGR